Profil Financier
Noubar Afeyan occupe actuellement le rang #1862 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.2 B (+$96 sur 24h).
Noubar Afeyan is the founder and CEO of Cambridge, Mass. life sciences innovation firm Flagship Pioneering.
He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020.
Afeyan has helped start more than 70 public and private healthcare and life sciences companies over the course of his career.
Born in Beirut, Lebanon, in 1962 to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975.
Beyond his stake in Moderna, he also owns shares in several publicly traded biotech companies in the U.S.
Afeyan was a lecturer at Harvard Business School until 2020 and also taught at MIT's Sloan School of Management from 2000 to 2016.
In 2014 he helped launch UWC Dilijan, an international boarding school in the town of Dilijan in the mountains of northern Armenia.